Receptor specificity of the antiarrhythmic effect produced by opioid peptides dalargin and DADLE during myocardial reperfusion

Bulletin of Experimental Biology and Medicine

Volumn 133, Issue 4, 2002, Pages 336-338

  Naryzhnaya, N V ^a,b   Maslov, L N ^a,b   Lishmanov, Yu B ^a,b   Gross, G J ^a,b  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

DADLE; Dalargin; Opioid receptors; Reperfusion arrhythmias

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; H TYROSYL 1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLIC ACID PHENYLALANYLPHENYLALANYLHYDROXIDE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; OPIATE PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE DURATION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION;

ANIMALS; ENKEPHALIN, LEUCINE-2-ALANINE; MALE; MYOCARDIAL REPERFUSION; RATS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 0036554835     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016229517353     Document Type: Article

References (10)

1. N. V. Korobov, Farmakol. Toksikol., No. 4, 35-38 (1988).
2. Yu. B. Lishmanov and L. N. Maslov, Opioid Neuropeptides, Stress, and Adaptive Protection of the Heart [in Russian], Tomsk (1994).
3. Yu. B. Lishmanov, L. N. Maslov, S. W. Tam, et al., Ros. Fiziol. Zh., 86, No. 2, 164-173 (2000).
4. T. J. Abbruscato, S. A. Thomas, V. J. Hruby, et al., J. Pharmacol. Exp. Ther., 280, No. 1, 402-409 (1997).
5. B. N. Dhawan, F. Cesselin, R. Raghubir, et al., Pharmacol. Rev., 48, No. 4, 567-592 (1996).
6. Yu. B. Lishmanov, L. N. Maslov, N. V. Naryzhnaya, and S. W. Tam, Life Sci., 65, No. 1, 13-17 (1999).
7. L. N. Maslov and Yu. B. Lishmanov, Int. J. Cardiol., 40, No. 2, 89-94 (1993).
8. T. Podzuweit, L. H. Opie, and W. F. Lubbe, Lancet, No. 1, 341-342 (1976).
9. J. A. Ruth and L. B. Eiden, Neuropeptides, No. 4, 101-108 (1984).
10. P. W. Schiller, G. Weltrowska, T. M.-D., Nguyen, et al., J. Med. Chem., 36, No. 21, 3182-3187 (1993).